Connect with us

National

Update on UQ COVID-19 vaccine – UQ News – UQ News

Phase 1 trial of the UQ-CSL v451 COVID-19 vaccine has shown that it elicits a robust response towards the virus and has a strong safety profile. There were no serious…

Published

on

post featured image

The University of Queensland and CSL today announce that the Phase 1 trial of the UQ-CSL v451 COVID-19 vaccine has shown that it elicits a robust response towards the virus and has a strong safety profile. There were no serious adverse events or safety concerns reported in the 216 trial participants. However, following consultation with the Australian Government, CSL will not progress the vaccine candidate to Phase 2/3 clinical trials.  
The University of Queensland commenced a Phase 1 trial of…

Click here to view the original article.